Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors.
about
Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanomaHistone deacetylase inhibitors: Potential in cancer therapyHistone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I studyClinical use and applications of histone deacetylase inhibitors in multiple myelomaSmall molecule inhibitors of zinc-dependent histone deacetylasesTargeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implicationsApplicability of histone deacetylase inhibition for the treatment of spinal muscular atrophyMechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer CellsEpigenetics in Brain Tumors: HDACs Take Center StageDimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drugThe role of histone deacetylase 7 (HDAC7) in cancer cell proliferation: regulation on c-MycA novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction, F-actin disruption and gene acetylation in lung cancerGene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancerTrichostatin A targets the mitochondrial respiratory chain, increasing mitochondrial reactive oxygen species production to trigger apoptosis in human breast cancer cellsYin Yang 1 is a repressor of glutamate transporter EAAT2, and it mediates manganese-induced decrease of EAAT2 expression in astrocytesPathways activated during human asthma exacerbation as revealed by gene expression patterns in bloodThe novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivoHistone deacetylase inhibitors for cancer therapy: An evolutionarily ancient resistance response may explain their limited successlimma powers differential expression analyses for RNA-sequencing and microarray studiesAn optimal test with maximum average power while controlling FDR with application to RNA-seq data.Integrating gene and protein expression data with genome-scale metabolic networks to infer functional pathwaysStatistical analysis of differential gene expression relative to a fold change threshold on NanoString data of mouse odorant receptor genes.Anti-leukemia activity of MS-275 histone deacetylase inhibitor implicates 4-1BBL/4-1BB immunomodulatory functions.HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells.Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphomaRefined annotation and assembly of the Tetrahymena thermophila genome sequence through EST analysis, comparative genomic hybridization, and targeted gap closurePhase 2 trial of romidepsin in patients with peripheral T-cell lymphoma.Brentuximab vedotin: treatment role for relapsed refractory systemic anaplastic large-cell lymphoma.Transcription-independent heritability of induced histone modifications in the mouse preimplantation embryo.Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice.Epigenetic responses to environmental change and their evolutionary implicationsExposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and function.Minireview: The versatile roles of lysine deacetylases in steroid receptor signalingHistone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions.Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur in vitro and in vivo and proceed through multiple mechanismsRNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea: a pilot case-control study.Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma.The clinical development of histone deacetylase inhibitors as targeted anticancer drugs.Intestinal epithelial barrier disruption through altered mucosal microRNA expression in human immunodeficiency virus and simian immunodeficiency virus infectionsStage prediction of embryonic stem cell differentiation from genome-wide expression data.
P2860
Q24606279-4BBF9CE1-8AFA-4FBB-9BDD-D12D6F48AAABQ24649025-49A4C993-0FC6-42FA-8F7E-24E71179D0A3Q24810933-C038D17E-CE3F-4384-B5F2-C20A32BF3373Q26745930-22CE6744-C473-428A-8C6C-47D21B3922DCQ26824515-630AF147-9957-42B0-9ACB-6B5A66C23523Q26853394-61A72080-E847-44E0-A1E8-58A1BBA06440Q26864605-6950EDE0-77E3-4FDF-8536-1DECC16C7E55Q27015931-8D9B1CD7-83ED-422F-814A-F9804BDB2A34Q28080964-696E70C6-7963-4F5C-B560-7D151682B85AQ28282479-39B95447-AF6F-4614-AEA9-BE749E5605BFQ28299585-3159C6B0-F4EA-4AFC-ACB2-A70D191DB1B3Q28475503-B64BE917-E20B-4E3C-934A-DFEA9FC277D9Q28477038-C7F6207C-B98E-4403-A624-DAD89B51F329Q28540870-3513B23F-9787-4151-8AB9-0247AFE933CEQ28583893-32CA0743-F53A-4BD1-A123-1D8680E34C20Q28742613-EA1BE6A6-8241-4A4C-9DF4-B4D856F6C078Q28751751-98CB75B9-1F04-4DDA-BEBD-7EB85C97CC17Q28822336-A2541F9E-742C-42BF-A2D1-9EFFECCF26AAQ29617988-6C3F4DEF-18AB-4D53-B8A5-56D8CE3A2356Q30657447-AA86500D-AEDB-4DFF-A8E5-C3D46BF23948Q30710200-717B69D0-9143-41FD-B0C5-DE527056887AQ30748167-FC58B842-7352-438A-88E2-6389969CC742Q30873726-05F71872-CF49-4786-8E65-13A98F277B9CQ33344484-D581F7C8-7EB3-4612-A7F3-BEAA0FA22EC3Q33386623-2F053EB2-B709-4385-869C-44ECCD02B9BEQ33387439-88B0AD3D-F516-4FB7-AEE4-C77938236F3CQ33394324-1DC167F3-8733-4666-8092-AB19FF234BCBQ33410081-558EF849-B949-42A9-9E4E-0C0FEE2BCC02Q33476149-73D02116-1C09-46C7-A7FB-CF1B7E2CF1CCQ33504871-BBA78EC6-2E94-42C9-8136-9F00C6D66502Q33510858-2CF8AFF2-D923-4020-B1CC-1DEBCDDDD869Q33570005-6E538019-54B0-4C5C-B1D8-8AEDD45C00CAQ33632070-3C112EE6-7674-4D15-B6BA-A2792F1D1C75Q33705588-C09AB300-2A7B-433B-8FCF-049852825816Q33761796-0D9FD607-1420-4CF5-8ADC-A6A1B1624205Q33764582-67D0388A-FC4B-474B-BF82-22FC8E41F88DQ33800456-B3868556-5ADE-4915-8FE6-37CF7C0FD19AQ33829390-E4975182-919C-4306-86D2-49E22D44E394Q33887767-2F9F51AD-0119-4F2E-B2CA-841D836DA307Q33963413-3CD83349-046E-4094-8CE4-D03061394118
P2860
Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Identification and functional ...... istone deacetylase inhibitors.
@ast
Identification and functional ...... istone deacetylase inhibitors.
@en
type
label
Identification and functional ...... istone deacetylase inhibitors.
@ast
Identification and functional ...... istone deacetylase inhibitors.
@en
prefLabel
Identification and functional ...... istone deacetylase inhibitors.
@ast
Identification and functional ...... istone deacetylase inhibitors.
@en
P2093
P2860
P50
P356
P1476
Identification and functional ...... istone deacetylase inhibitors.
@en
P2093
Andrew J Holloway
Melissa J Peart
Paul A Marks
Victoria M Richon
P2860
P304
P356
10.1073/PNAS.0500369102
P407
P577
2005-02-28T00:00:00Z